CAROL CRISP: Open Payments
NPI 1689730616 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 22 payments from 10 companies in 2025. Trend: 2023 $313 · 2024 $447 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $80 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $27 |
| Amgen Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: The Cologuard Plus Collection Kit, REXULTI, NURTEC ODT, ZENPEP, Wegovy, UBRELVY, ZORYVE, ISTURISA.
Industry payments across OR — which companies pay providers there.
